Ledger.Open graph →
SEC Form D · filed March 16, 2017

Diffusion Pharmaceuticals Inc

Offering
$25.0M
Sold
$15.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Robert W. Adams · Charlottesville, VADirectorBen L. Shealy · Charlottesville, VAExecThomas S. Byrne · Charlottesville, VAExecMark T. Giles · Charlottesville, VADirectorDavid G. Kalergis · Charlottesville, VAExec · DirectorAlan G. Levin · Charlottesville, VADirectorJohn L. Gainer · Charlottesville, VAExec · DirectorIsaac L. Blech · Charlottesville, VADirectorMudit F. Jain · Durham, NCExec · DirectorHorizon Capital Management and Research Limited · Kowloon Bay, Hong KongExecHorizon Investment Management Ltd · Grand Cayman, Cayman IslandsDirectorR. F. Mccoy, Jr · Durham, NCExecRichard M. Kelleher · Boston, MAExec · DirectorDouglas F. Reed · Durham, NCDirectorJames R. Dina · Boston, MADirectorCaroline K. Warren · Boston, MAExec · DirectorChristopher R. Devine · Boston, MADirectorWarren Q. Fields · Boston, MAExecPaul S. Holman · Pacific Grove, CADirectorLiz S. Haemmel · Pacific Grove, CAExecHeli S. Tattari · Pacific Grove, CAExec · DirectorTony S. Jones · Pacific Grove, CADirectorIsaac L. Blech · Charlottesville, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗